Neuralink, the brain chip startup founded by Elon Musk, says it has received approval to launch its first clinical trial in Canada for a device designed to give paralysed individuals the ability to use digital devices simply by thinking. Reuters reports: [T]he Canadian study aims to assess the safety and initial functionality of its implant which enables people with quadriplegia, or paralysis of all four limbs, to control external devices with their thoughts. Canada’s University Health Network hospital said in a separate statement that its Toronto facility had been selected to perform the complex neurosurgical procedure. Neuralink has successfully implanted the device in two patients in the United States. One of the patients has been using it to play video games and learn how to design 3D objects.